Metabolix (MBLX)

Add to Watchlists
Create an Alert
0.9402 -0.01  -1.03% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD

Metabolix Research and Development Expense (Quarterly):

4.681M for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Metabolix Research and Development Expense (Quarterly) Chart

Export Data
Save Image

Metabolix Historical Research and Development Expense (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 4.681M
Sept. 30, 2013 4.643M
June 30, 2013 4.945M
March 31, 2013 4.859M
Dec. 31, 2012 7.195M
Sept. 30, 2012 4.931M
June 30, 2012 5.006M
March 31, 2012 6.045M
Dec. 31, 2011 6.093M
Sept. 30, 2011 6.153M
June 30, 2011 6.00M
March 31, 2011
Dec. 31, 2010
Sept. 30, 2010
June 30, 2010
March 31, 2010
   
Dec. 31, 2009
Sept. 30, 2009
June 30, 2009
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

Get data for
Advertisement

MBLX Research and Development Expense (Quarterly) Benchmarks

Companies
Albemarle 22.57M
Cabot 16.00M
Chemtura 13.00M

MBLX Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 4.643M Sep 2013
Maximum 7.195M Dec 2012
Average 5.505M
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.